Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.

The US Food and Drug Administration (FDA) issued a complete response letter (CRL) regarding the Biologics License Application ...

Biosimilar natalizumab (Tyruko) is approved by EMA, US FDA, MHRA etc. and article is intended only for the HCP audience in ...

AstraZeneca announces update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus: Cambridge, UK Wednesday, February 4, 2026, 16:00 Hrs ...

Bristol Myers Squibb (NYSE: BMY) today reported fourth quarter and full-year 2025 financial results. Visit the company’s Investor Relations website at to view the detailed fourth quarter and ...

Rheumatologists share how they are using AI platforms for clinical documentation, reducing EHR time, streamlining workflows, ...

Chiranjeevi's Mana Shankara Vara Prasad Garu has emerged as a big success at the overseas box office, crossing the 40 crore mark.

February 2026 Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus The US Food and Drug Administration (FDA) issued a complete response letter (CRL) ...

EV Battery manufacturer CATL says it has effectively addressed one of the biggest anxieties in EV ownership: battery degradation from repeated DC fast charging. According to a report from InsideEVs, ...

In this PharmTech video feature, I highlight the week’s industry news in an easy-to-consume format. New roundups drop every ...

Q4 2025 earnings call highlights: revenue, cost cuts, cash outlook, FDA flu setback, and 2026 growth guidance—read key insights now.

A billionaire claims “all the pieces are in place” for an ETH bottom – this could be the moment that Ethereum price ...